Europe Artificial Cornea and Corneal Implant Market

Market Introduction

An artificial cornea implant is a surgery to eliminate all or part of a damaged cornea and replace it with healthy donor tissue. But, currently, there shortage of cornea donors worldwide, and eye and tissue banking is also not carrying in many countries. Meanwhile, there is always the possibility that the human eye will reject the transplantation, which can cause infection or lack of vision. Cornea Implant is usually performed under certain conditions such as keratoconus, degenerative disease, or other. The artificial cornea tissue can be made up of polymer plastic such as silica material. Artificial cornea implant is of two types, i.e., synthetic cornea implant and biosynthetic cornea implant.

Europe Artificial Cornea and Corneal Implant Strategic Insights

Strategic insights for the Europe Artificial Cornea and Corneal Implant provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Europe Artificial Cornea and Corneal Implant Report Scope

Europe Artificial Cornea and Corneal Implant Regional Insights

The geographic scope of the Europe Artificial Cornea and Corneal Implant refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Europe artificial cornea and corneal implant market is expected to reach US$ 196.62 million by 2028 from an estimated value of US$ 123.20 million in 2021; it is likely to grow at a CAGR of 7.4% from 2021 to 2028. The key factors that are driving the growth of market are rising prevalence of eye diseases that causes corneal blindness, significantly rising elderly population are factors propelling the artificial cornea and corneal implant market. However, the expensive ophthalmology surgeries and devices may hamper the growth of the Europe artificial cornea and corneal implant market in the forecast period.

Rise in geriatric population in developed countries such as the US, the UK and in developing countries such as China, India, and South Korea is driven by the modernization of healthcare facilities and improvements in healthcare services, which have boosted the life expectancy in these countries. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the world’s highest percentage of people of age more than 60, i.e., 25%. Further, by 2050, all regions of the world, except Africa, would have ~25% or more of their populations aged 60 and above. The loss of vision is a major health problem among the elderlies. At the age of 65, one-third of people suffer from an eye disease with impaired vision. Age-related macular degeneration, glaucoma, cataracts, and diabetic retinopathy are the most common causes of vision loss among the people from this age group. Age-related macular degeneration results in the loss of central vision. Optic nerve injury and visual field loss can occur as a result of primary open-angle glaucoma. As this ailment can be asymptomatic at first, elderly people should have regular check-ups. Although cataracts are a common source of visual issues in these people, surgeries to remove them is usually successful. Diabetic retinopathy is also common among the older people during the early stages of diabetes or at the time of diagnosis. When a patient is diagnosed with diabetes, a mydriatic examination is recommended, as well as once a year thereafter. Thus, the rise in geriatric population is fuelling the artificial cornea and corneal implant market growth.

In all European countries, the COVID-19 pandemic resulted in a significant reduction in living and deceased corneal donor and transplantation. The reduction varied between locations within a country and was different for deceased and living donors. In the United Kingdom, there was early signs of deceased donation recovery. Despite considerable resource redirection to combat the epidemic, certain policy modifications were implemented at the national and transplant center levels to ensure safe transplantation. However, the number of corneal transplant procedures in Italy is increasing for several months, and even if it does, there will be a shortage of available. The COVID-19 pandemic worst impacts hospital services. The hospitals are overloaded with COVID-19 patients and other routine patients. Many corneal donor specialists were reassigned to various tasks in ICUs and other COVID-19 related programmes. Due to the ongoing pandemic situation in the European regions, the hospitals in countries such as the UK, Italy, Germany, and others are affected worst affected.

Key Market Segments

The Europe artificial cornea and corneal implant market based on type is segmented into human cornea, and artificial cornea. In 2021, the human cornea segment is likely to hold the largest share of the market, however artificial cornea is expected to grow at the highest CAGR during the forecast period.

The Europe artificial cornea and corneal implant market based on the transplant type is segmented into penetrating keratoplasty, endothelial keratoplasty, and others. In 2021, the penetrating keratoplasty segment is likely to hold the largest share of the market however, endothelial keratoplasty is expected to grow at the fastest rate during the coming years.

The Europe artificial cornea and corneal implant market by disease indication, is segmented into Fuchs’ Dystrophy, keratoconus, fungal keratitis, others. The Fuchs’ Dystrophy segment is likely to hold the largest share of the market in 2021, however the fungal keratitis segment is anticipated to register the highest CAGR of the market during the forecast period.

The Europe artificial cornea and corneal implant market by end user, is segmented into hospitals, specialty clinics and ASCs and others. The specialty clinics and ASCs segment are likely to hold the largest share of the market in 2021 is anticipated to register the highest CAGR of the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Europe artificial cornea and corneal implant market are the Royal National Institute of Blind People (RNIB), Spanish National Institute of Statistics (INE) and Ministry of Health (MoH).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Europe artificial cornea and corneal implant market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Europe artificial cornea and corneal implant market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe artificial cornea and corneal implant market.

EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION

By

Type

• Human Cornea
• Artificial Cornea

By

Transplant Type

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Others

By Disease Indication

• Fuchs’ Dystrophy
• Keratoconus
• Fungal Keratitis
• Others

By End User

• Hospitals
• Specialty Clinics and ASCs
• Others

By Country

• AJL OPHTHALMIC S.A
• LinkoCare Life Sciences AB
• CORNEA BIOSCIENCES, INC
• EyeYon Medical
• Florida Lions Eye Bank